APA (7th ed.) Citation

M, M., A, Y., NA, A., O, S., A, A., K, H., . . . H, A. (2025). Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma. Hematology (Amsterdam, Netherlands), 30(1), 2515337. https://doi.org/10.1080/16078454.2025.2515337

Chicago Style (17th ed.) Citation

M, Ma'koseh, et al. "Dose Adjusted EPOCH-R Is Superior to RCHOP in Frontline Treatment of Mediastinal Large B Cell Lymphoma." Hematology (Amsterdam, Netherlands) 30, no. 1 (2025): 2515337. https://doi.org/10.1080/16078454.2025.2515337.

MLA (9th ed.) Citation

M, Ma'koseh, et al. "Dose Adjusted EPOCH-R Is Superior to RCHOP in Frontline Treatment of Mediastinal Large B Cell Lymphoma." Hematology (Amsterdam, Netherlands), vol. 30, no. 1, 2025, p. 2515337, https://doi.org/10.1080/16078454.2025.2515337.